Journal
FRONTIERS IN MICROBIOLOGY
Volume 10, Issue -, Pages -Publisher
FRONTIERS MEDIA SA
DOI: 10.3389/fmicb.2019.02233
Keywords
human cytomegalovirus; latency; induced pluripotent stem cells; C2-iPSCs; viral carriage; myeloid; dendritic cells; endothelial progenitor cells
Categories
Funding
- MRC Programme grant: RCUK \ Medical Research Council (MRC) [G:0701279]
- British Heart Foundation (BHF) [PG/14/31/]
- BHF Cambridge Centre of Research Excellence
- Cambridge National Institute for Health Research Biomedical Research Centre (NIHR BRC)
- Dinosaur Trust [DT001]
- MRC [MR/S00081X/1] Funding Source: UKRI
Ask authors/readers for more resources
Herpesviruses undergo life-long latent infection which can be life-threatening in the immunocompromised. Models of latency and reactivation of human cytomegalovirus (HCMV) include primary myeloid cells, cells known to be important for HCMV latent carriage and reactivation in vivo. However, primary cells are limited in availability, and difficult to culture and to genetically modify; all of which have hampered our ability to fully understand virus/host interactions of this persistent human pathogen. We have now used iPSCs to develop a model cell system to study HCMV latency and reactivation in different cell types after their differentiation down the myeloid lineage. Our results show that iPSCs can effectively mimic HCMV latency/reactivation in primary myeloid cells, allowing molecular interrogations of the viral latent/lytic switch. This model may also be suitable for analysis of other viruses, such as HIV and Zika, which also infect cells of the myeloid lineage.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available